marketcap
Facebook
X
TelegramAphria Inc. Kurzfristige Verbindlichkeiten 2011-2025 | APHA
Kurzfristige Verbindlichkeiten Jährlich Aphria Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 170 M | 139 M | 43.9 M | 10.3 M | 1.27 M | 947 K | 30 K | 11 K | 11 K | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 170 M | 11 K | 40.6 M |
Kurzfristige Verbindlichkeiten anderer Aktien in der Pharmaeinzelhändler
| Name | Kurzfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Graybug Vision
GRAY
|
4.03 M | $ 0.44 | -11.23 % | $ 9.65 M |  USA |
 |
AgeX Therapeutics
AGE
|
5.91 M | $ 11.3 | -10.17 % | $ 12.2 K | - |
 |
Galera Therapeutics
GRTX
|
1.67 M | $ 0.14 | -32.59 % | $ 7.61 M | USA |
 |
AnPac Bio-Medical Science Co., Ltd.
ANPC
|
42.3 M | $ 4.37 | -1.58 % | $ 28.1 M |  China |
 |
Axon Enterprise
AXON
|
1.68 B | $ 584.64 | -2.97 % | $ 44.3 B | USA |
 |
CollPlant Biotechnologies Ltd.
CLGN
|
2.97 M | $ 1.93 | -3.02 % | $ 22.1 M |  Israel |
 |
Cyclerion Therapeutics
CYCN
|
725 K | $ 1.8 | 10.97 % | $ 4.53 M | USA |
 |
Sorrento Therapeutics
SRNE
|
139 M | $ 0.27 | -29.58 % | $ 126 M | USA |
 |
ContraFect Corporation
CFRX
|
20.8 M | $ 1.47 | -5.16 % | $ 5.39 M | USA |
 |
Orchard Therapeutics plc
ORTX
|
60.6 M | $ 4.93 | 1.02 % | $ 90.8 M |  Britain |
 |
Advaxis
ADXS
|
25 M | $ 0.31 | -9.65 % | $ 45.9 M | USA |
 |
Heat Biologics, Inc.
HTBX
|
3.66 M | $ 3.93 | -5.76 % | $ 99.8 M | USA |
 |
La Jolla Pharmaceutical Company
LJPC
|
17.6 M | $ 6.2 | - | $ 154 M | USA |
 |
Zymeworks
ZYME
|
71.9 M | $ 6.42 | - | $ 404 M |  Canada |
 |
Checkmate Pharmaceuticals
CMPI
|
9.38 M | $ 10.5 | - | $ 231 M | USA |
 |
Kadmon Holdings, Inc.
KDMN
|
29.5 M | $ 9.5 | - | $ 1.7 B | USA |
 |
BioDelivery Sciences International
BDSI
|
82.4 M | $ 2.58 | -4.8 % | $ 255 M | USA |
|
Forte Biosciences
FBRX
|
9.08 M | $ 13.65 | 13.0 % | $ 87.3 M | USA |
 |
Zosano Pharma Corporation
ZSAN
|
11.1 M | $ 0.56 | 7.23 % | $ 2.72 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
7.54 M | $ 0.5 | - | $ 7.46 M | Israel |
 |
Kiromic BioPharma
KRBP
|
20.9 M | $ 3.15 | 6.61 % | $ 3.08 M | USA |
 |
Acceleron Pharma Inc.
XLRN
|
60.2 M | $ 179.68 | - | $ 10.9 B | USA |
 |
Genprex
GNPX
|
3.25 M | $ 4.17 | -0.95 % | $ 5.7 M | USA |
 |
Albireo Pharma
ALBO
|
45.3 M | $ 44.15 | -0.23 % | $ 916 M | USA |
 |
Stealth BioTherapeutics Corp
MITO
|
10.8 M | $ 0.32 | - | $ 23.9 M | USA |
 |
Trillium Therapeutics Inc.
TRIL
|
21.4 M | $ 18.44 | - | $ 1.94 B | Canada |
 |
Kaleido Biosciences
KLDO
|
29.7 M | $ 0.29 | -3.69 % | $ 12.4 M | USA |
 |
Entasis Therapeutics Holdings
ETTX
|
9.71 M | $ 2.19 | - | $ 105 M | USA |
 |
ImmuCell Corporation
ICCC
|
4.41 M | $ 6.16 | 0.98 % | $ 50.3 M | USA |
 |
IDEAYA Biosciences
IDYA
|
46.1 M | $ 30.82 | 1.9 % | $ 2.52 B | USA |
 |
Humanigen
HGEN
|
56.2 M | $ 0.04 | -81.12 % | $ 4.28 M | USA |
 |
Caladrius Biosciences
CLBS
|
5.61 M | $ 0.43 | -16.75 % | $ 25.8 M | USA |
 |
Aptinyx
APTX
|
6.29 M | $ 0.06 | -39.0 % | $ 4.57 M | USA |
 |
Tyme Technologies
TYME
|
5.64 M | $ 0.31 | 8.07 % | $ 54 M | USA |
 |
Jaguar Health
JAGX
|
19.7 M | $ 1.67 | -6.46 % | $ 492 K | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
25.2 M | $ 0.39 | - | $ 26.5 M | USA |
 |
Brickell Biotech
BBI
|
1.66 M | $ 2.11 | -5.38 % | $ 6.06 M | USA |
 |
Genocea Biosciences
GNCA
|
18.7 M | $ 0.05 | -15.0 % | $ 3.04 M | USA |
 |
Codiak BioSciences
CDAK
|
27.2 M | $ 0.06 | -55.98 % | $ 2.15 M | USA |
 |
Concert Pharmaceuticals
CNCE
|
16.1 M | $ 8.37 | - | $ 401 M | USA |
 |
AIkido Pharma
AIKI
|
3.78 M | $ 3.17 | 1.93 % | $ 17.4 M | USA |
 |
Krystal Biotech
KRYS
|
102 M | $ 199.71 | 0.9 % | $ 5.71 B | USA |
 |
Calithera Biosciences
CALA
|
14 M | $ 0.37 | -10.95 % | $ 876 K | USA |
 |
Forma Therapeutics Holdings
FMTX
|
35.1 M | $ 20.01 | - | $ 958 M | USA |
 |
Eli Lilly and Company
LLY
|
28.4 B | $ 967.93 | 4.71 % | $ 872 B | USA |